Peripheral Arterial Disease
Peripheral Arterial Disease
Peripheral Arterial Disease
Disease
Medical Nutrition Therapy
Human Nutrition and Dietetics
BY
Dr. Huma Umbreen
Definition
• Peripheral arterial disease (PAD) is a term used to describe occlusion
of blood flow in non-coronary arteries, and for the purpose of this
section of the text is limited to the lower extremities.
• Most PAD occurs in the pelvis and legs.
• Peripheral vascular disease is a term that includes diseases of the
veins.
• PAD has been used by some to describe all non-coronary
atherosclerotic disease.
Epidemiology
• The prevalence of the condition increases with age
• prevalence of PAD of 2% to 3% by age 50 and approximately 20% by
age 75
• Study found that 10% of the individuals with PAD had claudication,
50% had atypical leg pain, and 40% had no leg pain associated with
physical activity
• Strong association between vascular disease and damage to the
coronary disease leading to mortality
• Risk factors for the development of AS are important to the
development of PAD and are targets for treatment.
Cont….
• The most influential independent risk factors for PAD development and
progression are cigarette smoking and diabetes mellitus.
• In smokers, PAD development is increased 2 to 5 times.
• Smokers also are 8–10 times more likely to develop intermittent claudication
• Diabetic men have a higher rate of claudication than any other group.
• Diabetes in women eliminates the protective effect of estrogen so that their
risk is elevated to that of men with similar risk profiles.
• While dyslipidemia and hypertension are important and do increase risk of
PAD, they do not appear to be as influential as diabetes and cigarette
smoking
• The effect of hypertension on PAD appears to be much more subdued than
the effect in the cerebral or coronary arteries.
Pathophysiology
• An inflammatory response precedes the plaque rupture with
subsequent embolus formation
• The presence of PAD is also an indicator of ischemic disease in other
vascular beds; thus, the risk of MI, stroke, unstable angina, and
sudden cardiac death is increased in PAD patients.
• There are some small differences between the pathophysiology of
PAD and that of IHD.
• While thrombosis is known to play a critical role in all acute ischemic
incidents, it has been postulated that it has an even more important
role in acute ischemic events in those with PAD.
• in response to ischemia, collateral vessels will be developed to allow some blood
flow.
• The extent to which these vessels are formed and their contribution to function
seem to be determined to a great degree by the region in which the ischemia
occurs.
• Patients with PAD will eventually suffer from denervation of affected muscle
tissue.
• The ischemia of the tissue over time will cause this damage, which is thought to be
mediated by oxidative damage.
• The damage of denervation and alterations in muscle fiber type will reduce muscle
function.
• There is additional evidence of abnormal muscle cell metabolism in affected
tissues
Cont…..
• Mitochondrial expression increases in patients with PAD.
• While this is not uncommon to conditions that impair mitochondrial function, the
implication is that activities inside the muscle lead to its dysfunction.
• Accumulation of metabolic intermediates and products of incomplete metabolism
show state of metabolic disorder inside the muscle.
• Lactate levels at rest and during light workloads are elevated beyond that which
might be attributable to low blood/oxygen supply
• Th e electron transport chain suffers extensive oxidative damage as a result of PAD.
• Muscle tissue from PAD patients shows specific defects in the enzymes of the
electron transport chain.
• This damage can lead to increased reactive oxygen species formation and may
further metabolic injury.
• In addition, the increased free radical production can contribute to further
endothelial injury
Cont….